Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.
Legislation Quick Search
05/25/2024 10:49 AM
Pennsylvania House of Representatives
Home / House Co-Sponsorship Memoranda

House Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search

House of Representatives
Session of 2021 - 2022 Regular Session


Posted: December 4, 2020 02:10 PM
From: Representative Christina D. Sappey
To: All House members
Subject: Warning Labels on Prescription Opioid Containers
We must continue to find and utilize innovative solutions that will focus on harm reduction and the incidence of substance use disorder. That is why I will be introducing legislation that will require the State Board of Pharmacy to issue regulations requiring warning labels be added to opioid prescription bottles.
The addition of warning labels will ensure patients and their families across the Commonwealth are well-informed of the risks associated with opioid prescriptions every time they are used. In the United States, warning labels are already required on products, such as cigarettes and alcoholic beverages in order to inform the public about the health hazards that may result from their consumption or abuse. These labels have been shown to be an effective, low-cost method for communicating the product’s associated health risks. Warning labels on opioid prescriptions would serve as a consistent reminder of the potential dangers of abusing prescription medication.
Please join me in supporting this commonsense legislation.

Introduced as HB145